However, TCGA subgroup survival analysis has demonstrated that PLAUR mRNA expression significantly predicts PFS only in lung cancer patients, which potentially alludes to suPAR bearing predictive ability for PFS specifically in this cancer type. This evidence concerns the gene PLAUR and cancer.